Product Information
CLOTRIMAZOLE 1% VAGINAL CREAM is a generic product labeled by H2-Pharma LLC, priced at $0.0895 per GM under NDC 61269022041. Its NADAC has been published 237 times since Mar 23, 2022.
FDA first approved this application on Jul 16, 1993.
Strength
10 mg/g
Manufacturer
H2-Pharma LLCNDC
61269022041
Classification
Generic
Dosage Form
CREAM
Route
VAGINAL
Effective Date
9/23/2026
Active Ingredients
CLOTRIMAZOLEApproval Type
Generic (ANDA)
FDA Application
ANDA074165FDA Approved
7/16/1993
On Market Since
6/29/2021
Pharmacological Classes
Price Statistics
The NADAC for CLOTRIMAZOLE 1% VAGINAL CREAM has been published 237 times since Mar 23, 2022, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0895 per GM |
|---|---|
| All-time high | $0.0953 (Feb 15, 2023) |
| All-time low | $0.0663 (Jul 17, 2024) |
| 52-week high | $0.0895 |
| 52-week low | $0.0839 |
| Median price | $0.0882 |
| Average price | $0.0871 |
| Largest weekly change | +28.1% (Aug 21, 2024) |
| Weeks tracked | 237 |
| Tracking since | Mar 23, 2022 |
Generic Alternatives
The matcher finds 8 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 3% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
H2-Pharma LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Clotrimazole market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Azole Antifungal class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CLOTRIMAZOLE 1% VAGINAL CREAM?
The current National Average Drug Acquisition Cost (NADAC) for CLOTRIMAZOLE 1% VAGINAL CREAM, manufactured by H2-Pharma LLC, is $0.0895 per GM (NDC 61269022041), effective Sep 30, 2026.
How has the price of CLOTRIMAZOLE 1% VAGINAL CREAM changed over time?
Over the history we have for it, the NADAC for CLOTRIMAZOLE 1% VAGINAL CREAM has held within roughly two percent of its current level. It has been tracked across 237 weekly CMS publications since Mar 23, 2022.
What are the highest and lowest recorded NADAC prices for CLOTRIMAZOLE 1% VAGINAL CREAM?
Since Mar 23, 2022, the NADAC for CLOTRIMAZOLE 1% VAGINAL CREAM has ranged from a low of $0.0663 (Jul 17, 2024) to a high of $0.0953 (Feb 15, 2023), with a median of $0.0882 per GM.
Are there cheaper alternatives to CLOTRIMAZOLE 1% VAGINAL CREAM?
Yes. 8 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, FT CLOTRIMAZOLE 1% VAG CREAM, is $0.0865 per GM — about 3% below CLOTRIMAZOLE 1% VAGINAL CREAM.
Who manufactures CLOTRIMAZOLE 1% VAGINAL CREAM?
CLOTRIMAZOLE 1% VAGINAL CREAM (NDC 61269022041) is labeled by H2-Pharma LLC, and CMS classifies it as a generic product.